The Prince of Wales headed to Leeds, in northern England on Nov. 20 to open the Rob Burrow Centre for Motor Neurone Disease ...

Researchers in Australia have identified a three-drug combination that greatly extends the survival of motor neuron cells in ...

Sinfield revealed this year's ultramarathon challenge - taking in more than 50km (31 miles) each day - would take place in ...

A 19-year-old who was diagnosed with a rare form of motor neurone disease (MND) in August has said it is "disgusting" that ...

The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.

The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...

The FDA has approved Itvisma for the treatment of children two years and older, teens and adults living with spinal muscular ...

Novartis wins FDA approval for Itvisma, a one-time gene therapy offering broader SMA treatment with sustained motor function ...

Itvisma contains the active ingredient in Zolgensma approved in 2019 for children younger than 2 years but is reformulated ...

Wakefield Council looks set to adopt the Motor Neurone Disease (MND) Charter to support people in the district living with ...

The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in ...